Dr. Madan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3885 Oakwater Cir
Orlando, FL 32806Phone+1 407-816-5700Fax+1 407-438-9567
Summary
- Dr. Arvind Madan is a nephrologist in Orlando, FL and is affiliated with multiple hospitals in the area, including Orlando Regional Medical Center, Health Central Hospital, and AdventHealth Orlando. He received his medical degree from Maulana Azad Medical College and has been in practice 27 years. He also speaks multiple languages, including Hindi, Punjabi, and Urdu. He specializes in interventional nephrology and is experienced in general nephrology, interventional nephrology, dialysis, dialysis / vascular access placement, and electrolytes and dialysis access.
Education & Training
- SUNY Upstate Medical UniversityFellowship, Nephrology, 1995 - 1997
- Nassau University Medical CenterResidency, Internal Medicine, 1993 - 1995
- Maulana Azad Medical CollegeClass of 1990
Certifications & Licensure
- FL State Medical License 1999 - 2026
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Publications & Presentations
PubMed
- 36 citationsActhar gel in the treatment of nephrotic syndrome: a multicenter retrospective case seriesArvind Madan, Snezana Mijovic-Das, Ana Stankovic, Geoffrey Teehan, Amber S. Milward
BMC Nephrology. 2016-03-31 - 3 citationsRepository corticotropin injection in a patient presenting with focal segmental glomerulosclerosis, rheumatoid arthritis, and optic neuritis: a case report.Arvind Madan
International Journal of General Medicine. 2015-03-20
Journal Articles
- Optimal Tuberculosis Screening of Hemodialysis patientsArvind madan, Nephron, 8/4/1999
Authored Content
- #4337 UPDATED INTERIM RESULTS OF A PHASE 1/2 STUDY OF BION-1301 IN PATIENTS WITH IGA NEPHROPATHYJune 2023
- CT SUBMISSION NO. WCN23-1175 TITLE: UPDATED INTERIM RESULTS OF A PHASE 1/2 STUDY OF BION-1301 IN PATIENTS WITH IGA NEPHROPATHYMarch 2023
- Repository corticotropin injection in a patient presenting with focal segmental glomerulosclerosis, rheumatoid arthritis, and optic neuritis: a case reportMarch 2015
- Gentamicin effects on urinary electrolyte excretion in healthy subjectsJanuary 2000
- Join now to see all
Press Mentions
- Dr Nikki Kanani Appointed as England’s Top Family DoctorSeptember 4th, 2019
- Dr Nikita Kanani Appointed Primary Care Medical Director for NHS EnglandSeptember 4th, 2019
- How Technology Is Changing the GP ConsultationAugust 31st, 2018
- Join now to see all
Research History
- Founder and President NCCF.RResearch division of CFLKS2022 - Present
Professional Memberships
- Member
- Fl society of nephrology (FSN)Member
Other Languages
- Hindi, Punjabi, Urdu
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: